XTL Biopharmaceuticals Ltd. (XTLB)
2.53
-0.25
(-8.99%)
USD |
NASDAQ |
Aug 24, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 5.435M |
| September 30, 2024 | 5.717M |
| June 30, 2024 | 2.233M |
| March 31, 2024 | 2.705M |
| December 31, 2023 | 2.22M |
| September 30, 2023 | 2.501M |
| June 30, 2023 | 2.718M |
| March 31, 2023 | 3.081M |
| December 31, 2022 | 3.999M |
| September 30, 2022 | 4.744M |
| June 30, 2022 | 5.563M |
| March 31, 2022 | 5.844M |
| December 31, 2021 | 5.333M |
| September 30, 2021 | 3.079M |
| June 30, 2021 | 3.282M |
| March 31, 2021 | 4.367M |
| December 31, 2020 | 3.612M |
| September 30, 2020 | 6.028M |
| June 30, 2020 | 6.595M |
| March 31, 2020 | 7.025M |
| December 31, 2019 | 6.98M |
| September 30, 2019 | 8.089M |
| June 30, 2019 | 9.345M |
| March 31, 2019 | 12.20M |
| December 31, 2018 | 8.322M |
| Date | Value |
|---|---|
| September 30, 2018 | 7.272M |
| June 30, 2018 | 6.238M |
| March 31, 2018 | 6.197M |
| December 31, 2017 | 3.619M |
| September 30, 2017 | 3.62M |
| June 30, 2017 | 2.09M |
| March 31, 2017 | 3.502M |
| December 31, 2016 | 2.687M |
| September 30, 2016 | 3.825M |
| June 30, 2016 | 4.079M |
| March 31, 2016 | 4.386M |
| December 31, 2015 | 4.887M |
| September 30, 2015 | 7.223M |
| June 30, 2015 | 7.63M |
| March 31, 2015 | 4.637M |
| December 31, 2014 | 4.66M |
| September 30, 2014 | 5.393M |
| June 30, 2014 | 5.708M |
| March 31, 2014 | 6.142M |
| December 31, 2013 | 6.265M |
| September 30, 2013 | 7.323M |
| June 30, 2013 | 6.276M |
| March 31, 2013 | 6.826M |
| December 31, 2012 | 7.353M |
| September 30, 2012 | 7.119M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.67M |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 13.95M |
| Revium Recovery, Inc. | 18.10M |